ARMORED GPRC5D/BCMA BISPECIFIC CAR-T OVERCOMES THE TUMOR MICROENVIRONMENT TO ENHANCE ANTITUMOR EFFICACY

EHA Library, Xiaowen He, 4161217

AUC FLUDARABINE AND PRODUCT CHOICE ARE MAIN PREDICTORS OF CRS/ICANS AFTER CAR T CELL THERAPY: GENERATION OF AN IMPROVED MODEL

EHA Library, Keven Hoerster, 4161218

NCG-X: A NOVEL MOUSE MODEL FOR PRECLINICAL STUDIES EVALUATING HUMANIZED ERYTHROID RECONSTITUTION

EHA Library, Hongyan Sun, 4161219

FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FASTCAR-T GC012F (AZD0120) FOR PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

EHA Library, Jingjing Feng, 4161220

ANTI-BCMA/GPRC5D BISPECIFIC CAR T CELLS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE

EHA Library, Dian Zhou, 4161221

REDUCED OUTCOMES WITH PROTON PUMP INHIBITOR USE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CD19-DIRECTED CAR T-CELL THERAPY: A POPULATION-BASED ANALYSIS FROM THE DUTCH CAR T-CENTERS

EHA Library, Jaap Van Doesum, 4161222

MANAGEMENT OF IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME FOLLOWING CAR-T CELL THERAPY IN CLINICAL PRACTICE: A MULTICENTRIC, RETROSPECTIVE, REAL-WORLD ANALYSIS OF TREATMENT APPROACHES AND OUTCOMES

EHA Library, Veit Bücklein, 4161223

4-YEAR UPDATE OF PHASE 2 ELARA TRIAL: CLINICAL OUTCOMES OF TISAGENLECLEUCEL IN PATIENTS (PTS) WITH HIGH-RISK RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

EHA Library, Catherine Thieblemont, 4161224

PHASE 1/2 STUDY OF DONOR-DERIVED ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR T CELLS (VCAR33) FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Guenther Koehne, 4161225

DIAGNOSIS, PREDICTORS AND OUTCOMES FOR IMMUNE EFFECTOR CELL ASSOCIATED ENTEROCOLITIS IN MULTIPLE MYELOMA PATIENTS RECEIVING CILTA-CEL

EHA Library, Kenneth Jin Chang Lim, 4161226

EMAPALUMAB IN PEDIATRIC PATIENTS WITH HIGH-GRADE CYTOKINE RELEASE SYNDROME (CRS) FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY

EHA Library, Jing Zhang, 4161227

HYPOXIA-RESPONSIVE CEA CAR-T CELLS THERAPY FOR RELAPSED STAGE IV NON-SMALL CELL LUNG CANCER: A SINGLE-ARM, OPEN-LABEL, PHASE I TRIAL

EHA Library, Shuang Wei, 4161228

IMPACT OF PRE-LYMPHODEPLETION (PRE LD) AND DAY 30 (M1) IMMUNE CELL COUNTS ON OUTCOMES OF CAR T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Suheil Albert Atallah-Yunes, 4161229

CD19 CAR-T CELLS WITH ENHANCED TSCM IMMUNOPHENOTYPE PRODUCED BY PIGGYBAC TRANSPOSON SYSTEM FOR THE THERAPY OF REFRACTORY B-CELL MALIGNANCIES - PRELIMINARY RESULTS OF PHASE I CLINICAL TRIAL

EHA Library, Pavel Otáhal, 4161230

SINGLE-CELL IMMUNOPHENOTYPING OF CD19-CAR T CELLS IN PEDIATRIC BCP-ALL: INSIGHTS INTO CYTOKINE RELEASE SYNDROME AND TOCILIZUMAB-DRIVEN IMMUNE MODULATION.

EHA Library, Aleksandra Oszer, 4161231

PREGNANCY AND INFANT OUTCOMES POST-CD19-DIRECTED CAR-T THERAPY: TISAGENLECLEUCEL (TISA-CEL) AND/OR HUCAR19 (CTL119)

EHA Library, Marianne Ifversen, 4161232

LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA TREATED WITH PRIZLONCABTAGENE AUTOLEUCEL

EHA Library, Aibin Liang, 4161233

OPTIMIZED TRANSDUCTION OF MPB CD34+ CELLS INCREASE TRANSDUCTION EFFICIENCY AND VCN WHILE PRESERVING STEMNESS: TOWARDS A PHASE IIB CLINICAL TRIAL OF GENE THERAPY FOR TDT BETA-THALASSEMIA.

EHA Library, Samantha Scaramuzza, 4161234

INCIDENCE OF CARDIOTOXICITY IN OUTPATIENT CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES; A SINGLE CENTRE RETROSPECTIVE STUDY

EHA Library, Aminah Tayyab, 4161235

HIGH EFFICACY AND SAFETY OF A NOVEL ANTI-CD20 CAR-T CELL THERAPY, LY007 IN RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Lingshuang Sheng, 4161236

A MULTI-CENTER REAL-LIFE ANALYSIS ON PATIENTS WITH LARGE B-CELL LYMPHOMA AFTER FAILURE OF CAR-T CELLS THERAPY.

EHA Library, Mirko Farina, 4161237

COST-EFFECTIVENESS OF REGULAR RED BLOOD CELL EXCHANGE FOR PEDIATRIC SICKLE CELL DISEASE PATIENTS AT HIGH RISK OF STROKE: A HEALTH ECONOMIC ANALYSIS FROM THE FRENCH HEALTHCARE SYSTEM PERSPECTIVE

EHA Library, Ghofran Kamoun, 4161238

CORRELATION OF NON-INVASIVE HEMOGLOBIN MEASUREMENT TO VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Kunjan Rana, 4161239

PRELIMINARY PHARMACODYNAMIC BIOMARKER RESULTS IN PATIENTS WITH SICKLE CELL DISEASE FOLLOWING TREATMENT WITH OSIVELOTOR IN A MULTICENTER PHASE 2/3 TRIAL

EHA Library, Mira Pochron, 4161240

A COMPUTATIONAL ANALYSIS OF IMMUNE RECONSTITUTION DYNAMICS IN ADULTS WITH SICKLE CELL DISEASE UNDERGOING HLA-IDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Elisabeth Dovern, 4161241

ESTABLISHING CONSENSUS ON THE KEY COMPONENTS OF OPTIMAL TRANSITION FROM PAEDIATRIC TO ADULT CARE IN SICKLE CELL DISEASE ACROSS EUROPE

EHA Library, Mariangela Pellegrini, 4161242

REAL WORLD DATA ON PREVALENCE, CHARACTERISTICS AND OUTCOME OF MONOCLONAL GAMMOPATHIES IN ADULT SICKLE CELL DISEASE PATIENTS: A SINGLE CENTER EXPERIENCE.

EHA Library, Maria Dimopoulou, 4161243

EX VIVO ACTIVATION OF PYRUVATE KINASE BY TEBAPIVAT REDUCES SICKLING AND RED BLOOD CELL ADHESION IN SICKLE CELL DISEASE

EHA Library, Minke Rab, 4161244

MARKERS OF HEMOLYSIS AND CARDIAC FUNCTION IN SICKLE CELL DISEASE: A GENOTYPE-BASED ANALYSIS

EHA Library, Arman Sarshoghi, 4161245

INDIVIDUAL PATIENT ADHESIVE PHENOTYPES DEFINED BY FLOW ADHESION OF WHOLE BLOOD TO P-SELECTIN PREDICTS BIOLOGIC RESPONSE TO CRIZANLIZUMAB ADMINISTERED IN THE REAL WORLD CLINICAL SETTING

EHA Library, Jennell White, 4161246

SEROPREVALENCE OF SARS-COV-2 AND VACCINE EFFECTIVENESS IN INDIVIDUALS WITH SICKLE CELL DISEASE: COVIDODREP THE FRENCH MULTICENTER PROSPECTIVE STUDY.

EHA Library, Luu-Ly Pham, 4161247

MACHINE LEARNING-BASED DETECTION OF HEMOGLOBIN S AND HEMOGLOBIN C CARRIERS IN THE UK GENERAL POPULATION: A STUDY ON 469,248 GENOTYPED GENERAL POPULATION INDIVIDUALS FROM THE UK BIOBANK

EHA Library, Frederik Christensen, 4161248

POCIREDIR, A POTENT AND SELECTIVE EED INHIBITOR FOR THE TREATMENT OF SICKLE CELL DISEASE, INDUCES TARGET ENGAGEMENT AND GENE EXPRESSION CHANGES THAT ARE SPECIFIC AND REVERSIBLE IN WILD-TYPE MICE

EHA Library, Caterina Minniti, 4161249

IMPROVEMENT IN CEREBRAL OXYGEN SATURATIONS AND VASOREACTIVITY AFTER 12 MONTHS OF VOXELOTOR MEASURED BY NEAR-INFRARED SPECTROSCOPY (NIRS) IN SICKLE CELL DISEASE PATIENTS

EHA Library, Gonzalo De Luna, 4161250

MEEXCALC APP, A CALCULATOR FOR MANUAL ERITHROEXCHANGE IN SCD

EHA Library, Gian Luca Forni, 4161251

INNOVATIVE MODEL FOR CREATION AND USE OF CO-DEVELOPED PAIN MANAGEMENT PLANS FOR PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Abraham Haimed, 4161252

PATIENT-REPORTED VASO-OCCLUSIVE EVENTS, THEIR ASSOCIATED PAIN SEVERITY, AND IMPACT OF SICKLE CELL DISEASE ON FATIGUE AND QUALITY OF LIFE: A REAL-WORLD SURVEY IN THE UNITED STATES

EHA Library, Oladipo Cole, 4161253

INVESTIGATING THE RELATIONSHIP BETWEEN HIGH-SENSITIVITY TROPONIN, CLINICAL OUTCOMES AND HEMOLYTIC MARKERS IN ADULTS WITH SICKLE CELL DISEASE.

EHA Library, Najibah Galadanci, 4161254

UPDATED SAFETY AND EFFICACY RESULTS OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TREATING TRANSFUSION-DEPENDENT ß-THALASSEMIA

EHA Library, Hui Xu, 4161255

14-3-3Ζ COORDINATES CROSSTALK BETWEEN TRANSFERRIN RECEPTOR-1 AND ERYTHROPOIETIN RECEPTOR SIGNALING TO REGULATE ERYTHROID DIFFERENTIATION AND APOPTOSIS

EHA Library, Gorawin Chaiyakitpattana, 4161256

OVERALL SURVIVAL AND MORBIDITY AMONG ADULTS WITH THALASSEMIA IN ENGLAND: A RETROSPECTIVE ANALYSIS USING ROUTINELY COLLECTED HEALTHCARE DATA FROM 2008 TO 2020

EHA Library, Khaled M. Musallam, 4161257

LUSPATERCEPT UNDER AN ' EARLY ACCESS PROGRAM': AN ITALIAN MULTICENTRE EXPERIENCE

EHA Library, Raffaella Origa, 4161258

CHARACTERIZING THE GENETIC ARCHITECTURE OF DRUG RESPONSE IN TRANSFUSION-DEPENDENT THALASSEMIA

EHA Library, Anthony Iscaro, 4161259

REAL WORLD DATA ON IMPROVING ANEMIA WITHOUT TRANSFUSIONS WITH LUSPATERCEPT IN ß-THALASSEMIC PATIENTS WITH COMORBIDITIES AND/OR ALLOIMMUNIZATION, WHO CONVERT TO TRANSFUSION-DEPENDENT LATE IN ADULT LIFE.

EHA Library, Maria Dimopoulou, 4161260

CHANGES IN TRANSFUSION BURDEN AND IRON OVERLOAD PARAMETERS IN TRANSFUSION-DEPENDENT ß-THALASSEMIA PATIENTS TREATED WITH LUSPATERCEPT: A REAL-LIFE STUDY

EHA Library, Yesim Aydinok, 4161261

IMPACT OF GENE THERAPY ON PHYSICAL GROWTH OF PEDIATRIC PATIENTS WITH ß-THALASSEMIA: A PROSPECTIVE COHORT STUDY

EHA Library, Jingyu Zhao, 4161262

LEFT VENTRICULAR DIASTOLIC AND SYSTOLIC FUNCTIONS BY CARDIAC MAGNETIC RESONANCE IN TRANSFUSION-DEPENDENT BETA THALASSEMIA: CLINICAL AND OUTCOME CORRELATES

EHA Library, Antonella Meloni, 4161263

SURVIVAL OF PATIENTS WITH CONGENITAL RED BLOOD CELL DISORDERS IN COMPARISON WITH AGE, SEX AND ORIGIN MATCHED POPULATIONS: A DANISH REGISTER-BASED ANALYSIS

EHA Library, Dana Lawrie, 4161264

DISRUPTED AUTOPHAGY IN ß-THALASSEMIA: A NEW LINK BETWEEN HEMICHROME CLEARANCE, MITOCHONDRIAL DYSFUNCTION AND INEFFECTIVE ERYTHROPOIESIS

EHA Library, Emanuele Tanzi, 4161265

ROXYSCAN ASSESSES PYRUVATE KINASE ACTIVATOR'S EFFECT ON OXIDATIVE STRESS SENSITIVITY IN ß-THALASSEMIA PATIENTS: AN ANCILLARY STUDY OF THE ENERGIZE/ ENERGIZE-T CLINICAL TRIALS

EHA Library, Eduard J. van Beers, 4161266

TNFα-NFKB DEREGULATION IS CRITICAL FOR CONTROLLING THE HSC POOL AND COMMITMENT IN BETA-THALASSEMIA

EHA Library, Giulia Chianella, 4161267

A NEW METHOD FOR ANALYZING BONE MARROW CELL POPULATIONS BY SPECTRAL FLOW CYTOMETRY

EHA Library, Laura BRAUD, 4161268

INCREASED ALL-CAUSE MORTALITY AMONG PATIENTS DIAGNOSED WITH WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA COMPARED TO THE GENERAL POPULATION: A NATIONWIDE REGISTER STUDY IN SWEDEN

EHA Library, Christian Kjellander, 4161269

IMPACT OF RILZABRUTINIB ON BIOMARKERS OF INFLAMMATION AND COMPLEMENT FACTORS IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): RESULTS FROM THE PHASE 2 STUDY

EHA Library, Nichola Cooper, 4161271

THE CDIN1-CODANIN-1 COMPLEX, DEFECTIVE IN CONGENITAL DYSERYTHROPOIETIC ANAEMIA TYPE I, IS A RNA NUCLEASE

EHA Library, Sanja Brolih, 4161272

RED BLOOD CELL AGE DISTRIBUTION AND METABOLIC FEATURES IN HEREDITARY SPHEROCYTOSIS, HEREDITARY XEROCYTOSIS AND CONGENITAL DYSERYTHROPOIETIC ANEMIA - BASELINE RESULTS OF EXPLORATORY ANALYSIS FROM THE SATISFY STUDY

EHA Library, Richard VAN WIJK, 4161273

TARGETING STAT1 AS A POTENTIAL THERAPEUTIC APPROACH FOR AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Linhui Hu, 4161274

PIEZO1 GAIN-OF-FUNCTION DRIVES GLYCOLYTIC IMBALANCE IN LATE-STAGE ERYTHROPOIESIS: THE POTENTIAL OF MITAPIVAT THERAPY IN DEHYDRATED HEREDITARY STOMATOCYTOSIS

EHA Library, Barbara Eleni Rosato, 4161275

DATA MANAGEMENT PRACTICES AND BENEFITS OF NATIONAL DATA MANAGEMENT COORDINATION IN RARE ANAEMIA DISORDERS REGISTRIES: RADEEP IN ITALY, A CASE STUDY

EHA Library, Roberta Trapanese, 4161276

ELLAGIC ACID ALLEVIATES IRON OVERLOAD-INDUCED LIVER DAMAGE BY MITIGATING FERROPTOSIS THROUGH MODULATION OF THE TGFß/SMAD SIGNALING PATHWAY

EHA Library, Hangjie Fu, 4161278

IMPROVEMENT OF ANEMIA AND KIDNEY STATUS BY SEVUPARIN TREATMENT IN A MOUSE MODEL OF CHRONIC KIDNEY DISEASE

EHA Library, Michela Asperti, 4161279

DIFFERENTIAL ROLES FOR CELL CYCLE REGULATIONS BETWEEN TRANSFERRIN AND FERRITIN JUSTIFY THE DEVELOPMENT OF TRANSFERRIN RECEPTOR 1 BLOCKERS AS ANTINEOPLASTIC AGENTS OVER IRON CHELATORS

EHA Library, Ryo Yanagiya, 4161280

SINGLE- AND MULTIPLE-ASCENDING DOSES OF DISC-3405, A RECOMBINANT HUMANIZED ANTIBODY TARGETING TMPRSS6, INCREASED HEPCIDIN AND REDUCED IRON AND HEMATOCRIT IN HEALTHY VOLUNTEERS

EHA Library, Marcus Carden, 4161281

STRIKE THE IRON WHILE IT'S LOW: REDEFINING IRON DEFICIENCY IN WOMEN

EHA Library, Ayesha Shameem, 4161282

REAL-WORLD SAFETY PROFILE OF DEFERIPRONE TWICE-A-DAY (DFP BID) FOR TRANSFUSIONAL IRON OVERLOAD IN PATIENTS IN THE UNITED STATES WITH THALASSEMIA, SICKLE CELL DISEASE (SCD) OR OTHER ANEMIAS

EHA Library, Sujit Sheth, 4161283

RESULTS FROM THE HELIOS STUDY: A PHASE 2, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA

EHA Library, Melanie Chin, 4161284

INTRAVENOUS IRON RELATED HYPOPHOSPHATEMIA AND POTENTIAL PREVENTING ROLE OF VITAMIN D SUPPLEMENTATION:„REAL LIFE” DATA FROM AN OUTPATIENTS CLINIC IN NORTH ITALY

EHA Library, Giovanni Inghilleri, 4161285

FERRITIN INDEX OF SOLUBLE TRANSFERRIN RECEPTOR AND IRON STATUS BIOMARKERS FOR IRON DEFICIENCY ANEMIA DIAGNOSIS - COMPARISON AND CORRELATION WITH IRON THERAPY RESPONSE

EHA Library, Nina Petkova, 4161286

PREDICTIVE MACHINE LEARNING MODEL FOR SCREENING IRON DEFICIENCY WITHOUT ANEMIA USING AVAILABLE DATA FROM ELECTRONIC HEALTH RECORDS

EHA Library, Shelly Soffer, 4161287

NATIONWIDE STUDY OF SECONDARY CARE INFECTIONS AND INFECTION-RELATED DEATH IN PATIENTS WITH MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Ingrid Glimelius, 4161288

CMV VIREMIA IN NON-TRANSPLANT ADOLESCENT AND ADULT PATIENTS TREATED WITH ACUTE LYMPHOBLASTIC LEUKEMIA PROTOCOLS

EHA Library, Hamsa Murli, 4161289

MVA-BASED GEO-CM04S1 VACCINE RESULTS IN IMPROVED CELLULAR IMMUNE RESPONSE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) COMPARED WITH MRNA-BASED VACCINE: INITIAL RESULTS OF A PHASE II RANDOMIZED STUDY

EHA Library, Alexey Danilov, 4161290

CLINICAL IMPACT OF METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS) OF PLASMA CELL-FREE DNA FOR THE DIAGNOSIS OF INFECTIOUS DISEASES IN PATIENTS WITH HEMATOLOGICAL DISORDERS

EHA Library, shanfeng hao, 4161291

EPIDEMIOLOGY AND SEVERITY OF PARVOVIRUS B19 INFECTION IN RED BLOOD CELL DISORDERS DURING THE EPIDEMIC SEASON 2023-2024: A NATIONWIDE REPORTFROM ITALIAN AIEOP CENTRES

EHA Library, Maria Paola Boaro, 4161292

WORLDWIDE EXPERIENCE OF CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION: A MULTINATIONAL RETROSPECTIVE COHORT STUDY

EHA Library, chunrui li, 4161293

AGGRESSIVE CLINICAL FEATURES AND POOR OUTCOME MAY ASSOCIATE WITH DECREASED IMMUNE FUNCTION IN HIV POSITIVE HL IN THE CART ERA: A MULTICENTER STUDY FROM CHINA

EHA Library, Chaoyu Wang, 4161294

CLINICAL CHARACTERISTICS AND OUTCOMES OF SEPSIS-INDUCED COAGULOPATHY AND DISSEMINATED INTRAVASCULAR COAGULATION FOLLOWING ALLO-HSCT

EHA Library, Qiu-sha Huang, 4161295

LUNG MICROBIOTA ALTERATIONS IN HEMATOLOGICAL MALIGNANCY PATIENTS WITH PNEUMOCYSTIS PNEUMONIA

EHA Library, Giovangiacinto Paterno, 4161296

CLINICAL JOURNEY AND IMMUNOGLOBULIN-REPLACEMENT THERAPY IN PATIENTS WITH MULTIPLE MYELOMA AND SEVERE OR RECURRENT INFECTIONS

EHA Library, Elisabet Viayna, 4161297

MATCHED COHORT STUDY COMPARING THE IMPACT OF RSV, INFLUENZA, AND SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES

EHA Library, Francesco MARCHESI, 4161298

IMMATURE PLATELET FRACTION AS A PREDICTOR OF PLATELET COUNT RECOVERY AND BLEEDING OCCURRENCE IN PATIENTS UNDERGOING INTENSIVE INDUCTION THERAPY FOR ACUTE LEUKEMIA.

EHA Library, Maha EL AMANI, 4161299

IMPACT OF IMMUNE PLATELET REFRACTORINESS IN THE TREATMENT COURSE OF ACUTE LEUKEMIA ADULT PATIENTS AT A TERTIARY CENTER

EHA Library, Anna Arrufat Bel, 4161300

UPFRONT TRANSFUSION OF NON-LEUKOREDUCED LOW-TITER GROUP O+ WHOLE BLOOD IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED 30-DAY SURVIVAL IN SEVERELY INJURED CIVILIAN TRAUMA PATIENTS

EHA Library, Eldad Dann, 4161301

AUDIT ON THE ADHERENCE TO BRITISH SOCIETY OF HAEMATOLOGY GUIDELINES IN A TERTIARY CARE CENTRE

EHA Library, Silvia Lovato, 4161302

MONITORING THE HEMODYNAMIC QUALITY OF STORED BLOOD UNITS FOR IMPROVED TRANSFUSION OUTCOME, BY DETERMINING RED CELL MEMBRANE COMPONENTS

EHA Library, Saul Yedgar, 4161303

TO TRANSFUSE OR NOT TO TRANSFUSE A BABY: THAT IS THE QUESTION!

EHA Library, Filipa Fonseca-Dias, 4161304

EFFECTIVENESS AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF ADULTS WITH NEWLY DIAGNOSED, PERSISTENT, OR CHRONIC IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS FROM THE PHASE 4 ADOPT STUDY

EHA Library, Waleed Ghanima, 4161305

UNRAVELING ITP PATHOGENESIS: A SINGLE-CELL AND IMMUNE REPERTOIRE ANALYSIS OF T AND B LYMPHOCYTES

EHA Library, Marianna Ciuffeda, 4161306

REAL-WORLD EFFICACY AND SAFETY OF FOSTAMATINIB FOR ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: ITALIAN MULTICENTER EXPERIENCE. FINAL RESULTS OF THE GIMEMA ITP1122 STUDY

EHA Library, Elisa Lucchini, 4161307

EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF PEDIATRIC IMMUNE THROMBOCYTOPENIA IN THE OPEN-LABEL EXTENSION OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

EHA Library, Rachael F. Grace, 4161308

INBORN ERRORS OF IMMUNITY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Nehal Joshi, 4161309

PREDICTING RESPONSE TO RITUXIMAB TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA BY IMMUNE PROFILING

EHA Library, Alicia Au, 4161310

IANALUMAB' S DUAL MECHANISM OF ACTION: TARGETING B CELLS THROUGH ENHANCED B-CELL DEPLETION AND BLOCKADE OF B CELL-ACTIVATING FACTOR RECEPTOR SIGNALING

EHA Library, Christoph Burkhart, 4161311

CLINICAL IMPACT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH SOLID TUMORS

EHA Library, Austin Nuschke, 4161312

REAL-WORLD TREATMENT PATTERNS & CLINICAL OUTCOMES IN THROMBOPOIETIN RECEPTOR AGONIST NAIVE PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH AVATROMBOPAG: INTERIM RESULTS FROM THE REAL-AVA 3.0 STUDY

EHA Library, Sandhya Panch, 4161313

CLINICAL FACTORS ASSOCIATED WITH RESPONSE TO RILZABRUTINIB, A BRUTON TYROSINE KINASE (BTK) INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) TREATED IN THE PHASE 3 LUNA3 STUDY

EHA Library, David Kuter, 4161314

CLINICAL CHARACTERISTIC OF ISOLATED THROMBOCYTOPENIA IN PATIENTS WITH BONE MARROW FAILURE-RELATED GERMLINE VARIANTS: A RETROSPECTIVE STUDY FROM A SINGLE CENTRE

EHA Library, Diijong Wu, 4161315

EFFECTIVENESS AND SAFETY OF AVATROMBOPAG FOR TREATMENT OF IMMUNE THROMBOCYTOPENIA IN OLDER PATIENTS AND THOSE WITH COMORBIDITIES OR PRIOR TPO-RA EXPOSURE: INTERIM RESULTS FROM THE PHASE 4 ADOPT STUDY

EHA Library, María Eva Mingot-Castellano, 4161316

EFFECT OF EFGARTIGIMOD IV ON IMMATURE PLATELET COUNT FRACTION IN PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Francesco Zaja, 4161317

RESPONSE TO AVATROMBOPAG AMONG PATIENTS WITH CHRONIC AND ACUTE/PERSISTENT PRIMARY IMMUNE THROMBOCYTOPENIA: THE REAL-AVA 2.0 REAL-WORLD STUDY

EHA Library, MY Levy, 4161318